Document Detail

The relationship between inflammatory activity and brain atrophy in natalizumab treated patients.
MedLine Citation:
PMID:  22391507     Owner:  NLM     Status:  Publisher    
OBJECTIVE: To assess the evolution of brain atrophy and its relationship with inflammatory activity in RRMS patients treated with natalizumab. METHODS: Eighteen RRMS patients were prospectively followed up for 18 months after starting natalizumab therapy. Patients were monitored monthly and assessed for signs of relapses, adverse events or disability increase. MRI scans were performed before starting natalizumab and every six months. Cross-sectional T2 lesion volume (T2LV) and the normalized brain volume (NBV) at baseline and 18 months MRI scans were calculated using the Steronauta(®) and SIENAx softwares, respectively. Longitudinal Percentage of Brain Volume Change (PBVC) was estimated with SIENA. Linkage between inflammatory activity and brain atrophy was studied. RESULTS: Natalizumab reduced ARR by 67% and cumulative CEL by 87.5%. T2 lesion volume decreased from 1000mm(3), to 960mm(3) (p=0.006) and NBV decreased from 1.55×10(5)mm(3) to 1.42×10(5) mm(3) (p=0.025). Global PBVC from baseline to 18 months was -2.5%, predominantly during the first six months (0-6 months PBVC -1.7%; 6-12 months PBVC -0.74%; 12-18 months PBVC -0.50%). The number of relapses before treatment was correlated to the PBVC during the first semester (Pearson's coefficient -0.520, p=0.003), while the number of basal CEL or baseline T2LV did not correlate with brain atrophy rate. During follow-up, nine patients had clinical or radiological inflammatory activity. Their PBVC was significantly higher in the first semester (-2.3% to -1.1%, p=0.002). CONCLUSIONS: Natalizumab reduced relapse rate and CEL in MRI. Brain atrophy predominated in the first semester and was related to previous inflammatory activity.
M Magraner; F Coret; B Casanova
Related Documents :
4084867 - A pilot study on the use of botulinum toxin in spasmodic torticollis.
7966077 - Comparison of adrenocorticotropic hormone and triamcinolone acetonide in the treatment ...
18296027 - Efficacy of methylprednisolone injected into the masseter muscle following the surgical...
9339787 - Refinement in the rehabilitation of the paralyzed face using botulinum toxin.
15598707 - The influence of previous and concomitant leflunomide on the efficacy and safety of inf...
15369507 - Recent changes in the management of primary hiv-1 infection: results from the french pr...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-3-3
Journal Detail:
Title:  European journal of radiology     Volume:  -     ISSN:  1872-7727     ISO Abbreviation:  -     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-3-6     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8106411     Medline TA:  Eur J Radiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012. Published by Elsevier Ireland Ltd.
Multiple Sclerosis Unit, Neurology Service, Hospital Universitari i Politècnic La Fe, Bulevar Sur s/n, 46026 Valencia, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The stabilizing role of the rotator cuff at the shoulder-responses to external perturbations.
Next Document:  Single-nucleotide polymorphisms associated with skin naphthyl-keratin adduct levels in workers expos...